Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00474773 · ClinicalTrials.gov registry record
Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery
A clinical trial, sponsored by St. Louis Joint Replacement Institute.
- Completed
- Registry status
- 107
- Enrollment target
NCT00474773: Completed study, sponsored by St. Louis Joint Replacement Institute.
NCT00474773 is a clinical trial that has completed, run by St. Louis Joint Replacement Institute. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00474773 has completed, sponsored by St. Louis Joint Replacement Institute.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
This study will evaluate the benefits of continuing celecoxib through six weeks of total knee arthroplasty recovery. This is a randomized, double blind study with a group of approximately 130 primary total knee patients. All patients will receive celecoxib throughout their hospitalization as per current minimally invasive total knee arthroplasty protocol. At the time of hospital discharge, participating patients will be randomly placed on either celecoxib 200mg twice a day or a placebo twice a day. This study will determine if the continued use of celecoxib for six weeks after total knee arthroplasty hospitalization will further decrease narcotic consumption, improve knee range of motion, improve ambulatory ability, and improve patient satisfaction over patients receiving celecoxib only during the acute hospitalization.
Interventions
- DRUG Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-12 |
What the finished NCT00474773 record still lists
NCT00474773 is an observational study that tracks outcomes without assigning an intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Celecoxib is the first listed.
NCT00474773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00474773 about?
NCT00474773 is a clinical study titled "Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery". This study will evaluate the benefits of continuing celecoxib through six weeks of total knee arthroplasty recovery. This is a randomized, double blind study with a group of approximately 130 primary total knee patients. All patients will receive celecoxib throughout their hospitalization as per cur...
What is the current status of trial NCT00474773?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2007-06. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00474773?
The interventions under investigation include: Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00474773?
This trial is sponsored by St. Louis Joint Replacement Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia